4//SEC Filing
Bush Tia L 4
Accession 0001470831-25-000192
CIK 0001847903other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 5:50 PM ET
Size
16.0 KB
Accession
0001470831-25-000192
Insider Transaction Report
Form 4
Bush Tia L
Chief Technology & Quality Ofc
Transactions
- Exercise/Conversion
Ordinary Shares
2025-09-09$8.01/sh+24,792$198,584→ 146,295 total - Exercise/Conversion
Ordinary Shares
2025-09-10$9.42/sh+25,000$235,500→ 146,503 total - Sale
Ordinary Shares
2025-09-10$22.00/sh−25,000$550,000→ 121,503 total - Exercise/Conversion
Share Option (right to buy)
2025-09-10−25,000→ 475,338 totalExercise: $9.42Exp: 2031-05-07→ Ordinary Shares (25,000 underlying) - Sale
Ordinary Shares
2025-09-09$20.00/sh−24,792$495,840→ 121,503 total - Exercise/Conversion
Share Option (right to buy)
2025-09-09−24,792→ 145,208 totalExercise: $8.01Exp: 2034-02-01→ Ordinary Shares (24,792 underlying)
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2024.
- [F3]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.
- [F4]25% of the shares subject to such option shall vest and become exercisable on May 20, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001863418
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 5:50 PM ET
- Size
- 16.0 KB